The effect of Alzheimer’s disease and its progression on pyramidal cell gain and connectivity
View ORCID ProfileJuliette H Lanskey, Amirhossein Jafarian, Melek Karadag, Ece Kocagoncu, Rebecca Williams, Pranay Yadav, Andrew J Quinn, Jemma Pitt, Tony Thayanandan, Stephen Lowe, Michael Perkinton, Maarten Timmers, Vanessa Raymont, Krish D Singh, Mark Woolrich, Anna C Nobre, Richard N Henson, James B Rowe, the NTAD study group
doi: https://doi.org/10.1101/2024.04.11.24305662
Juliette H Lanskey
1MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, UK
Amirhossein Jafarian
1MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, UK
2Department of Clinical Neurosciences and Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, UK
Melek Karadag
2Department of Clinical Neurosciences and Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, UK
Ece Kocagoncu
2Department of Clinical Neurosciences and Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, UK
Rebecca Williams
1MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, UK
Pranay Yadav
1MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, UK
Andrew J Quinn
3Centre for Human Brain Health, School of Psychology, University of Birmingham, UK
4Oxford Centre for Human Brain Activity, Wellcome Centre for Integrative Neuroimaging, Department of Psychiatry, University of Oxford, Oxford, UK
Jemma Pitt
4Oxford Centre for Human Brain Activity, Wellcome Centre for Integrative Neuroimaging, Department of Psychiatry, University of Oxford, Oxford, UK
Tony Thayanandan
4Oxford Centre for Human Brain Activity, Wellcome Centre for Integrative Neuroimaging, Department of Psychiatry, University of Oxford, Oxford, UK
Stephen Lowe
5Lilly Corporate Center, Indianapolis, USA
Michael Perkinton
6Neuroscience, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK
Maarten Timmers
7Neuroscience External Innovation, Johnson & Johnson Innovations, London, UK
Vanessa Raymont
8Department of Psychiatry, University of Oxford, Oxford, UK
Krish D Singh
9Cardiff University Brain Research Imaging Centre, School of Psychology, Cardiff University, Cardiff, UK
Mark Woolrich
4Oxford Centre for Human Brain Activity, Wellcome Centre for Integrative Neuroimaging, Department of Psychiatry, University of Oxford, Oxford, UK
Anna C Nobre
4Oxford Centre for Human Brain Activity, Wellcome Centre for Integrative Neuroimaging, Department of Psychiatry, University of Oxford, Oxford, UK
Richard N Henson
1MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, UK
10Department of Psychiatry, University of Cambridge, Cambridge, UK
James B Rowe
1MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, UK
2Department of Clinical Neurosciences and Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, UK
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
Imaging data and clinical scores are hosted by Dementias Platform UK Imaging Platform (https://portal.dementiasplatform.uk), using XNAT (https://www.xnat.org). Data will be made available with a managed access process through Dementias Platform UK, subject to requesters agreeing to a Code of Conduct to preserve data security, confidentiality and privacy.
Posted April 12, 2024.
The effect of Alzheimer’s disease and its progression on pyramidal cell gain and connectivity
Juliette H Lanskey, Amirhossein Jafarian, Melek Karadag, Ece Kocagoncu, Rebecca Williams, Pranay Yadav, Andrew J Quinn, Jemma Pitt, Tony Thayanandan, Stephen Lowe, Michael Perkinton, Maarten Timmers, Vanessa Raymont, Krish D Singh, Mark Woolrich, Anna C Nobre, Richard N Henson, James B Rowe, the NTAD study group
medRxiv 2024.04.11.24305662; doi: https://doi.org/10.1101/2024.04.11.24305662
The effect of Alzheimer’s disease and its progression on pyramidal cell gain and connectivity
Juliette H Lanskey, Amirhossein Jafarian, Melek Karadag, Ece Kocagoncu, Rebecca Williams, Pranay Yadav, Andrew J Quinn, Jemma Pitt, Tony Thayanandan, Stephen Lowe, Michael Perkinton, Maarten Timmers, Vanessa Raymont, Krish D Singh, Mark Woolrich, Anna C Nobre, Richard N Henson, James B Rowe, the NTAD study group
medRxiv 2024.04.11.24305662; doi: https://doi.org/10.1101/2024.04.11.24305662
Subject Area
Subject Areas
- Addiction Medicine (339)
- Allergy and Immunology (665)
- Anesthesia (179)
- Cardiovascular Medicine (2621)
- Dermatology (220)
- Emergency Medicine (396)
- Epidemiology (12163)
- Forensic Medicine (10)
- Gastroenterology (754)
- Genetic and Genomic Medicine (4054)
- Geriatric Medicine (383)
- Health Economics (674)
- Health Informatics (2617)
- Health Policy (996)
- Hematology (359)
- HIV/AIDS (840)
- Medical Education (397)
- Medical Ethics (109)
- Nephrology (429)
- Neurology (3824)
- Nursing (208)
- Nutrition (569)
- Oncology (2004)
- Ophthalmology (580)
- Orthopedics (238)
- Otolaryngology (303)
- Pain Medicine (250)
- Palliative Medicine (73)
- Pathology (470)
- Pediatrics (1107)
- Primary Care Research (445)
- Public and Global Health (6495)
- Radiology and Imaging (1385)
- Respiratory Medicine (868)
- Rheumatology (399)
- Sports Medicine (338)
- Surgery (440)
- Toxicology (52)
- Transplantation (185)
- Urology (165)